title: Induction of endolymphatic hydrops in the guinea pig by perisaccular deposition of sepharose beads carrying and not carrying immune complexes.
abstract: We tried to induce endolymphatic hydrops in guinea pig cochleas by unilateral, perisaccular deposition of sepharose beads carrying immune complexes. Controls consisted of the deposition of sepharose beads without immune complexes and the contralateral, untreated ear. The effects of the treatment were studied by light microscopy and electrophysiological recordings of the gross cochlear potentials 1, 2, and 6 weeks after treatment. Each condition included six animals. Analysis of variance of the morphometric data concerning the ears treated with deposition of the beads showed a statistically significant difference (P = 0.04) between the degree of hydrops found for the beads with immune complexes and for those without. The difference between the treated ears and the contralateral untreated ears was significant (P = 0.01) for the beads with immune complexes and not significant (P = 0.8) for those without immune complexes while there was no significant effect of post-treatment time interval. Analysis of variance of the electrophysiological data, collected in response to tone bursts at the apex of the cochlea, showed no significant differences between the results for the beads with and without immune complexes. Therefore these results were pooled. One week after treatment the pooled results for the compound action potential showed a small decrease in amplitude, just significant at 2 kHz, but not at 4 and 8 kHz. This decrease disappeared completely after 6 weeks. The pooled results for the negative summating potential (SP) showed a significant increase in magnitude at all frequencies decreasing with post-treatment interval. The cochlear microphonics did not demonstrate any change in amplitude after treatment. The results indicate that deposition of sepharose beads with immune complexes induces endolymphatic hydrops. Also, deposition of the sepharose beads itself may have induced hydrops together with enhancement of the SP. SP enhancement may be related to the development of endolymphatic hydrops rather than to the presence of hydrops as such. This may be based on pressure build-up while hydrops develops.
authors.affiliation: Department of Otorhinolaryngology, University Hospital, Utrecht, The Netherlands.
authors.forename: H
authors.initials: H
authors.lastname: Bouman
authors.forename: S F
authors.initials: SF
authors.lastname: Klis
authors.forename: J C
authors.initials: JC
authors.lastname: de Groot
authors.forename: E H
authors.initials: EH
authors.lastname: Huizing
authors.forename: G F
authors.initials: GF
authors.lastname: Smoorenburg
authors.forename: J E
authors.initials: JE
authors.lastname: Veldman
mesh_terms: D000200:Action Potentials / Q000187:drug effects; D000704:Analysis of Variance; D000818:Animals; D000936:Antigen-Antibody Complex; D001300:Audiometry, Evoked Response; D003051:Cochlea / Q000503:physiopathology; D003055:Cochlear Microphonic Potentials / Q000187:drug effects; D004195:Disease Models, Animal; D004337:Drug Carriers; D004710:Endolymph / Q000187:drug effects / Q000276:immunology; D018159:Endolymphatic Hydrops / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D006168:Guinea Pigs; D007105:Immune Complex Diseases / Q000209:etiology; D008575:Meniere Disease / Q000209:etiology; D009195:Peroxidase / Q000737:chemistry; D012444:Saccule and Utricle / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D012685:Sepharose
chemical_list: D000936:Antigen-Antibody Complex; D004337:Drug Carriers; D012685:Sepharose; D009195:Peroxidase